Cytokine Networks and the Clinical Outcome of American Teg-Umentary Leishmaniasis: Unveiling Targets for Alternative Therapeutic Interventions
Pathogens · 2025
DOI: 10.3390/pathogens14020188 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathogens, 2025. Verfasst von Carolina Cattoni Koh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Morphology, Institute of Biological Sciences, Federal University of Minas Gerais, Av. Pres. Antônio Carlos, 6627-Pampulha, Belo Horizon…. Hauptthemen laut MEDLINE: Cytokines, Leishmaniasis, Cutaneous, Leishmaniasis, Mucocutaneous, Leishmania. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Fundação de Amparo `a Pesquisa do Estado de Minas Gerais (FAPEMIG), Instituto Nacional de Ciência e Tecnologia em Doenças Tropicais (INCT-DT).
Abstract (Originalsprache)
American Tegumentary Leishmaniasis (ATL), caused by parasites of the genus Leishmania, presents a significant global health challenge, especially in Brazil, where cutaneous and mucosal forms are highly prevalent. Cutaneous Leishmaniasis (CL) typically results in single lesions, while mucosal Leishmaniasis (ML) leads to destructive mucosal lesions with a worse prognosis. The immune response, regulated by cytokines, plays a crucial role in disease progression and resolution. In CL, a balance between pro-inflammatory and anti-inflammatory cytokines is associated with lesion resolution, whereas in ML, an exaggerated inflammatory response worsens tissue damage. Thus, understanding cytokine regulation is essential for unveiling disease pathology and developing effective immunotherapeutic strategies. Here we discuss gene polymorphisms and epigenetic modifications that affect cytokine expression, influencing disease susceptibility and severity, as well as immunotherapeutic approaches that involve cytokine function in Leishmaniasis. In addition, we examine advancements in drug discovery, utilizing in silico methods and targeted drug delivery systems, providing potential avenues for better therapeutic interventions. Continuous research into immune responses and cytokine production and function is critical for identifying novel therapeutic targets and optimizing patient care for ATL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Morphology, Institute of Biological Sciences, Federal University of Minas Gerais, Av. Pres. Antônio Carlos, 6627-Pampulha, Belo Horizonte 31270-901, MG, Brazil.
- National Institute of Science and Technology in Tropical Diseases, INCT-DT, Salvador 40110-160, BA, Brazil.
- Hospital Israelita Albert Einstein, São Paulo 05652-900, SP, Brazil.
ORCID-Profile: Carolina Cattoni Koh, Kenneth J Gollob, Walderez O Dutra
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
- Fundação de Amparo `a Pesquisa do Estado de Minas Gerais (FAPEMIG)
- Instituto Nacional de Ciência e Tecnologia em Doenças Tropicais (INCT-DT)
- National Institutes of Health (NIH)
Zitieren
APA
Koh, C. C., Gollob, K. J., & Dutra, W. O. (2025). Cytokine Networks and the Clinical Outcome of American Teg-Umentary Leishmaniasis: Unveiling Targets for Alternative Therapeutic Interventions. Pathogens. https://doi.org/10.3390/pathogens14020188
Vancouver
Koh CC, Gollob KJ, Dutra WO. Cytokine Networks and the Clinical Outcome of American Teg-Umentary Leishmaniasis: Unveiling Targets for Alternative Therapeutic Interventions. Pathogens. 2025. doi:10.3390/pathogens14020188
BibTeX
@article{Koh2025,
author = {Koh, Carolina Cattoni and Gollob, Kenneth J and Dutra, Walderez O},
title = {Cytokine Networks and the Clinical Outcome of American Teg-Umentary Leishmaniasis: Unveiling Targets for Alternative Therapeutic Interventions},
journal = {Pathogens},
year = {2025},
doi = {10.3390/pathogens14020188}
}
EUVIMED